![logo](/logos/ETON.webp)
Eton Pharmaceuticals, Inc.
NASDAQ:ETON
4.59 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Eton Pharmaceuticals, Inc. |
Symbool | ETON |
Munteenheid | USD |
Prijs | 4.59 |
Beurswaarde | 118,588,158 |
Dividendpercentage | 0% |
52-weken bereik | 3.03 - 5.81 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Sean E. Brynjelsen |
Website | https://www.etonpharma.com |
An error occurred while fetching data.
Over Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)